Access Challenges of Advanced Therapy Medicinal Products in Europe

被引:0
|
作者
Szulc, E. [1 ]
Tschumi, B. [1 ]
Pennese, N. [1 ]
Lecureuil, C. [1 ]
Robbins, S. [1 ]
机构
[1] LatticePoint Consulting, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA201
引用
收藏
页码:S336 / S336
页数:1
相关论文
共 50 条
  • [1] Europe's Advanced Therapy Medicinal Products: chances and challenges
    Mertsching, Heike
    Walles, Thorsten
    EXPERT REVIEW OF MEDICAL DEVICES, 2009, 6 (02) : 109 - 110
  • [2] Challenges and opportunities for access to Advanced Therapy Medicinal Products in Brazil
    Sachetti, Camile Giaretta
    Barbosa Jr, Augusto
    de Carvalho, Antonio Carlos Campos
    Araujo, Denizar Vianna
    da Silva, Everton Nunes
    CYTOTHERAPY, 2024, 26 (08) : 939 - 947
  • [3] MARKET ACCESS TRENDS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN EUROPE
    Dellamano, R.
    Mycka, J.
    Lobb, W.
    Dellamano, L.
    Dalal, N.
    VALUE IN HEALTH, 2018, 21 : S465 - S465
  • [4] ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) MARKET ACCESS CHALLENGES IN FRANCE
    Hoceini, K.
    Tano, M.
    Siorat, V
    Parent de Curzon, O.
    Degrassat-Theas, A.
    Paubel, P.
    VALUE IN HEALTH, 2022, 25 (12) : S325 - S325
  • [5] Managing access to advanced therapy medicinal products: Challenges for NHS Wales
    Champion, Andrew R.
    Lewis, Sian
    Davies, Stuart
    Hughes, Dyfrig A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2444 - 2449
  • [6] THE CHALLENGES OF OUTCOMES-BASED REIMBURSEMENT FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Wallace, M.
    Redman, N.
    VALUE IN HEALTH, 2022, 25 (12) : S251 - S251
  • [7] REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S202 - S203
  • [8] GMP Challenges for Advanced Therapy Medicinal Products
    Milmo, Sean
    BIOPHARM INTERNATIONAL, 2015, 28 (12) : 12 - 14
  • [9] THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S428 - S428
  • [10] Challenges in development, market authorisation and commercialisation of advanced therapy medicinal products in Europe: A cohort study
    ten Ham, ten Renske M. T.
    Hoekman, Jarno
    Hovels, Anke M.
    Broekmans, Andre W.
    Leufkens, Hubert G. M.
    Klungel, Olaf H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 428 - 428